FenoMark Diagnostics AB
@fenomarkdiagnostics.com
Dedicated to improving cancer care by developing better diagnostic assays for therapy selection.
FenoMark Diagnostics AB's Company Logos
FenoMark Diagnostics AB's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#66BBCD
Downy
102, 187, 205
190, 51, 60
50, 9, 0, 20
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About FenoMark Diagnostics AB
FenoMark Diagnostics is a leading developer of biomarkers for selecting the best therapeutics to aid cancer patients worldwide. As a spin-out of Karolinska Institutet in Stockholm, Sweden, the founders of FenoMark Diagnostics have accumulated over 4 decades of cancer research experience. They have a strong focus on biomarker discovery using state-of-the-art methods developed in-house.
The vision of FenoMark Diagnostics is to reveal the true phenotype of each cancer through advanced proteomics and genomics, ultimately contributing to better cancer therapies. With a dedicated team led by Lukas Orre, the Chief Scientific Officer and Co-Founder, who has over 15 years of experience in cancer therapy and biomarker research, FenoMark Diagnostics strives to make a significant impact in the field. Supported by Janne Lehtiö, the Chairman and Co-Founder, who is a key opinion leader in Clinical Proteomics with a remarkable track record of over 120 academic publications, FenoMark Diagnostics combines expertise and innovation.
To stay informed about career opportunities at FenoMark Diagnostics, please reach out to careers@fenomarkdiagnostics. com. For more information, contact them at info@fenomarkdiagnostics.
com
Company type
Privately Held
Year founded
2019
Company size
2-10 employees
